share_log
Reuters ·  Nov 13, 2024 13:33
Eagle Pharmaceuticals-Expects to Conclude One or More Material Weaknesses Related to the Matters Existed in Internal Control Over Financial Reporting
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 223
Write a comment